Interestingly, Metha et al. (2022) found that CHAC1 overexpression in various breast cancer cells is often driven by hypomethylation of its promoter region, particularly in tumors harboring mutant TP53 (Mehta et al., 2022). Here, TP53 is linked to breast carcinoma.